84314-36-3

Basic information

• Product Name: 1-(4-hydroxy-phenyl)-3-(2-hydroxy-phenyl)-propane-1,3-dione
• Synonyms: 1-(4-hydroxy-phenyl)-3-(2-hydroxy-phenyl)-propane-1,3-dione
• CAS NO: 84314-36-3
• Molecular Weight: 256.258
• Mol File: 84314-36-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-(4-hydroxy-phenyl)-3-(2-hydroxy-phenyl)-propane-1,3-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-hydroxy-phenyl)-3-(2-hydroxy-phenyl)-propane-1,3-dione(84314-36-3)
• EPA Substance Registry System: 1-(4-hydroxy-phenyl)-3-(2-hydroxy-phenyl)-propane-1,3-dione(84314-36-3)

Safety Data

• Hazardous Substances Data: 84314-36-3(Hazardous Substances Data)

Upstream product

• 99-96-7 4-hydroxy-benzoic acid 
• 2345-34-8 4-acetyloxy-benzoic acid 
• 141993-06-8 3-(4-hydroxyphenyl)-5-tributylstannylisoxazole 
• 533-58-4 2-Iodophenol 
• 82340-49-6 3-(4-hydroxyphenyl)-5-(2-hydroxyphenyl)-isoxazole 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 118-93-4 o-hydroxyacetophenone 

Downstream Products

• 84314-50-1 2-(4-Chloro-phenyl)-3-(4-hydroxy-benzoyl)-chromen-4-one 
• 84314-48-7 3-(4-Hydroxy-benzoyl)-2-(4-methoxy-phenyl)-chromen-4-one 
• 84314-51-2 3-(4-Hydroxy-benzoyl)-2-(2-hydroxy-phenyl)-chromen-4-one 
• 84314-49-8 3-(4-Hydroxy-benzoyl)-2-(4-nitro-phenyl)-chromen-4-one 
• 4143-63-9 4'-hydroxyflavone 
• 84314-42-1 1-(4-Hydroxy-phenyl)-3-(2-hydroxy-phenyl)-2-[1-(2-hydroxy-phenyl)-meth-(E)-ylidene]-propane-1,3-dione 
• 84314-39-6 1-(4-Hydroxy-phenyl)-3-(2-hydroxy-phenyl)-2-[1-(4-methoxy-phenyl)-meth-(E)-ylidene]-propane-1,3-dione 
• 84314-40-9 1-(4-Hydroxy-phenyl)-3-(2-hydroxy-phenyl)-2-[1-(4-nitro-phenyl)-meth-(E)-ylidene]-propane-1,3-dione 
• 84314-41-0 2-[1-(4-Chloro-phenyl)-meth-(E)-ylidene]-1-(4-hydroxy-phenyl)-3-(2-hydroxy-phenyl)-propane-1,3-dione 

Relevant articles and documents

STILBENES AND CHALCONES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

A Convenient Synthesis of Flavones. Synthesis of Apigenin

-